The import of heterocyclic compounds and quinoline ring into the US is forecasted to decline gradually from 2024 to 2028. In 2024, the imports are projected to be $153.55 million USD, reducing significantly to $87.963 million USD by 2028. Compared to 2023, where the import stood higher, this indicates a consistent downward trend over the forthcoming years. Year-on-year variation shows a considerable reduction in imports each year, with a negative CAGR reflecting the persistent decline over these five years.
Future Trends to Watch:
- Regulatory changes or trade policies affecting the chemical sector.
- Advancements in alternative synthetic pathways that could reduce dependency on imports.
- Market shifts due to emerging pharmaceutical demands or environmental guidelines.
- Technological advancements in domestic production to offset imports.
